Skip to main content
. Author manuscript; available in PMC: 2009 Nov 4.
Published in final edited form as: J Am Geriatr Soc. 2009 Apr;57(4):686–690. doi: 10.1111/j.1532-5415.2009.02200.x

Table 3.

Multivariate models of the likelihood of taking medications among the 578 patients with Mild Cognitive Impairment (MCI).

Characteristic Anti-AD* Medications Statins Antioxidants Folic Acid
Odds Ratio (95% Confidence Interval)
Age 1.26 (1.01 – 1.57) --- --- ---
Education 1.39 (1.06 – 1.82) --- 1.42 (1.07 – 1.89) 1.34 (0.83 – 2.16)
Non-White Race --- --- --- 2.32 (1.01 – 5.31)
Male 1.26 (0.84 – 1.89) 1.58 (1.10- 2.27) --- 2.84 (1.26 – 6.42)
MMSE* 0.87 (0.70 – 1.09) --- --- ---
Diabetes --- 2.40 (1.52 – 3.80) 0.53 (0.29 – 0.98) ---
Hypertension --- 2.19 (1.48 – 3.24) --- ---
Myocardial Infarct --- 4.34 (2.03 – 9.26) --- ---
Stroke/TIA* --- 1.25 (0.73 – 2.12) --- 0.31 (0.07 – 1.37)
BRDRS* 1.76 (1.38 – 2.24) --- --- 1.72 (1.27 – 2.34)
Site 1.00 (0.93 – 1.09) 0.95 (0.89 – 1.02) 1.13 (1.04 – 1.22) 1.04 (0.91 – 1.20)
Amnestic Disorder 1.83 (1.18 – 2.85) 1.08 (0.70 – 1.67) --- 0.68 (0.26 – 1.75)
Mild Neurocognitive
Disorder
--- 0.61 (0.40 – 0.91) 0.75 (0.46 – 1.24) ---
MCI*- Petersen or
ADCS Criteria
0.65 (0.42 – 1.00) --- 1.01 (0.62 – 1.63) ---
*

AD = Alzheimer's Disease; MMSE = Mini Mental Status Examination (range = 0 – 30 where lower score indicates poorer performance); TIA = transient ischemic attack; BRDRS = Blessed-Roth Dementia Rating Scale (range = 0 – 17 where higher score indicates poorer performance)